303A COLLEGE ROAD EAST, PRINCETON, NJ
To Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
PDS Biotech Publishes VERSATILE-002 Phase 2 Trial Results in JAMA Oncology
Investor Presentation
Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors
Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
PDS Biotechnology Enters First Amendment to $6M Promissory Note
Material disclosure
Janetta Trochimiuk Appointed Interim Principal Accounting Officer
Q2
Q1
Amended Annual Report
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Definitive Revised Proxy Statement